ANAB in the 13F filings
Anaptysbio Inc · CUSIP 032724106
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 10 Feb 2026
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 4 listed it in both
- Shares listed
- 6,227,407
- combined, among listed positions
- Reported value
- $302m
- combined, at the quarter end
Among the 92 comparable managers: 12 buyers (opened or added shares) and 13 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -719,252.
Managers listing ANAB in Q4 2025
24 of 24 holders
Largest increases and reductions, by shares
Increases
- D. E. Shaw & Co.existing position · 670,288 shares now+320,928
- Voloridge Investment Management LLCexisting position · 229,137 shares now+219,816
- Arrowstreet Capital LPexisting position · 559,744 shares now+189,286
- Squarepoint Ops LLCexisting position · 160,731 shares now+92,717
- Citadel Advisors LLCexisting position · 109,483 shares now+83,003
Reductions
- Millennium Management LLCexisting position · 813,571 shares now-705,659
- Point72 Asset Management LPexisting position · 1,932,890 shares now-332,638
- T. Rowe Price Associates Incexisting position · 26,005 shares now-273,306
- Jane Street Group LLCexisting position · 84,447 shares now-96,665
- Renaissance Technologies LLCexisting position · 76,300 shares now-47,000
New positions and exits
New (2)
Exited (5)
- Susquehanna International Group LLPwas $4.4m
- Walleye Capital LLCwas $1.7m
- Marshall Wace LLPwas $1.7m
- Brevan Howard Capital Management LPwas $775k
- Man Group PLCwas $394k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2017 | 1 | $8.6m | n.a. | n.a. |
| Q4 2017 | 5 | $544m | n.a. | n.a. |
| Q1 2018 | 8 | $673m | n.a. | n.a. |
| Q2 2018 | 4 | $271m | n.a. | n.a. |
| Q3 2018 | 6 | $860m | n.a. | n.a. |
| Q4 2018 | 5 | $579m | n.a. | n.a. |
| Q1 2019 | 6 | $670m | n.a. | n.a. |
| Q2 2019 | 5 | $350m | n.a. | n.a. |
| Q3 2019 | 5 | $190m | n.a. | n.a. |
| Q4 2019 | 2 | $2.4m | n.a. | n.a. |
| Q1 2020 | 3 | $3.7m | n.a. | n.a. |
| Q2 2020 | 2 | $6.2m | n.a. | n.a. |
| Q3 2020 | 1 | $948k | n.a. | n.a. |
| Q4 2020 | 2 | $17m | n.a. | n.a. |
| Q1 2021 | 1 | $9.2m | n.a. | n.a. |
| Q2 2021 | 1 | $14m | n.a. | n.a. |
| Q3 2021 | 2 | $32m | n.a. | n.a. |
| Q4 2021 | 3 | $31m | n.a. | n.a. |
| Q1 2022 | 2 | $53m | n.a. | n.a. |
| Q2 2022 | 2 | $36m | n.a. | n.a. |
| Q3 2022 | 2 | $93m | n.a. | n.a. |
| Q4 2022 | 2 | $86m | n.a. | n.a. |
| Q1 2023 | 2 | $47m | n.a. | n.a. |
| Q2 2023 | 2 | $51m | n.a. | n.a. |
| Q3 2023 | 3 | $17m | n.a. | n.a. |
| Q4 2023 | 4 | $45m | 2 | 2 |
| Q1 2024 | 3 | $34m | 2 | 2 |
| Q2 2024 | 1 | $6.3m | 0 | 1 |
| Q3 2024 | 3 | $22m | 3 | 0 |
| Q4 2024 | 1 | $6.4m | 1 | 2 |
| Q1 2025 | 3 | $60m | 3 | 0 |
| Q2 2025 | 3 | $67m | 1 | 2 |
| Q3 2025 | 4 | $97m | 1 | 2 |
| Q4 2025 | 4 | $137m | 12 | 13 |
| Q1 2026 | 2 | $20m | 16 | 12 |
| Q2 2026 | 1 | $48m | 12 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ANAB and LLY →ANAB and JNJ →ANAB and VRTX →Choose a stock to compare with ANAB →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ANAB, latest filings →Back to the 13F Explorer →